XL413 - CAS 1169558-38-6

XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the activity of CDC7, which may result in the inhibition of DNA replication and mitosis, the induction of tumor cell apoptosis, and the inhibition of tumor cell proliferation in CDC7-overexpressing tumor cells.

Cholecystokinin Receptor, Casein Kinase, Pim, CDK

Chromatin/Epigenetic, Cell Cycle/Checkpoint, JAK/STAT signaling, Stem Cells, Metabolism, GPCR/G Protein

1169514

>99.99%

C14H12ClN3O2

289.72

O=C1C2=C(C=3C(O2)=CC=C(Cl)C3)NC(=N1)[C@@H]4CCCN4

-20°C

Ice Packs

Small Compound